Buscar resultados de ensayos clínicos
Mucocutaneous Lymph Node Syndrome - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease Condición: Kawasaki Disease Fecha: 2008-09-25 Intervenciones:
|
Completed |
Nombre del estudio: Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012 Condición: Kawasaki Disease Fecha: 2014-12-08 |
Recruiting |
Nombre del estudio: A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease Condición: Kawasaki Disease Fecha: 2016-10-28 Intervenciones:
|
Withdrawn |
Nombre del estudio: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Condición: Kawasaki Disease Fecha: 2016-10-24 Intervenciones: Drug: Canakinumab Other Name: ACZ885 |
Recruiting |
Nombre del estudio: Etiology Study of Kawasaki Disease Condición: Kawasaki Disease Fecha: 2005-09-09 |
Completed |
Nombre del estudio: Infliximab (Remicade) for Patients With Acute Kawasaki Disease Condición: Kawasaki Disease Fecha: 2005-12-30 Intervenciones:
|
Completed |
Nombre del estudio: Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease Condición: Kawasaki Disease Fecha: 2012-01-25 Intervenciones: Drug: immunoglobulin G Intravenously administer a single dose of the product (2g/kg) for at least 12 hou |
Completed |
Nombre del estudio: A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease Condición: Kawasaki Disease Fecha: 2005-09-09 Intervenciones: Drug: Sestamibi Sestamibi Other Name: Cardiolite |
Completed |
Nombre del estudio: Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease Condición: Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin Fecha: 2012-05-09 Intervenciones:
|
Recruiting |
Nombre del estudio: Anakinra and Kawasaki Disease Condición:
Fecha: 2015-03-11 Intervenciones: Drug: Anakinra The dose of Anakinra will be 2mg/kg. If the patient remains febrile (fever >38°C) |